If you have been reading about lyophilized powder and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-11-28. Numbers and descriptions here follow the published literature rather than marketing material.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
Laboratory handling centers on minimizing exposure to water, heat and oxygen before use. Working solutions are typically prepared in sterile water or a mild buffer, and any residual particulate matter is removed by filtration. When the powder dissolves slowly, a small proportion of acetonitrile or dilute acetic acid is sometimes added as a co-solvent. Containers are kept sealed and desiccated between uses. Records of lot number, reconstitution date and storage conditions support later comparison of results across experiments.
Identity and purity are established with reversed phase high performance liquid chromatography coupled to mass spectrometry. The chromatographic step separates the target peptide from truncated sequences and deletion products, while the mass measurement confirms the expected molecular weight to within a fraction of a dalton. Because the two common variants differ by the presence of the linker, mass alone can distinguish them in the unconjugated state. Amino acid analysis and peptide mapping are used when sequence level confirmation is required.
Lyophilized material is generally stable for extended periods when held at minus twenty degrees Celsius or below and protected from moisture and light. In solution the peptide is more labile; bond hydrolysis, aggregation and oxidation of susceptible residues all proceed faster at ambient temperature. Repeated freeze and thaw cycles should be avoided because they promote clumping and loss of soluble material. The conjugated variant adds a further consideration, since the maleimide group can hydrolyze in aqueous buffer and lose its ability to react with albumin.
| Property | Value | Notes |
|---|---|---|
| Target receptor | GHRH receptor (GHRHR) | Expressed on pituitary somatotrophs |
| Primary action | Stimulates growth hormone release | Amplifies pulse size |
| Half-life, albumin-binding form | Several days as reported | Slow release from albumin complex |
| Half-life, unmodified analog | About 30 minutes in animal estimates | Cleared by proteases and filtration |
| Common analytical approach | LC-MS/MS for peptide, immunoassay for hormones | Methods answer different questions |
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.
Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.
The two variants differ dramatically in how long they persist in circulation. The form lacking the albumin-binding group has a plasma half-life measured in tens of minutes, comparable to the natural hormone fragment. The version carrying the drug affinity complex binds albumin and shows a half-life of roughly six to eight days in human studies. That figure comes from small trials that tracked hormone levels over extended periods. The physiological consequences of sustained versus pulsatile stimulation are still debated and the literature does not settle the point.
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
Two registrational trials have evaluated vaccine candidates in active immunization strategies against S. aureus infection. In a phase II trial, a bivalent vaccine of capsular proteins 5 & 8 was tested in 1804 hemodialysis patients with a primary fistula or synthetic graft vascular access. After 40 weeks following vaccination a protective effect was seen against S. aureus bacteremia, but not at 54 weeks following vaccination. Based on these results, a second trial was conducted which failed to show efficacy. Merck tested V710, a vaccine targeting IsdB, in a blinded randomized trial in patients undergoing median sternotomy. The trial was terminated after a higher rate of multiorgan system failure–related deaths was found in the V710 recipients. Vaccine recipients who developed S. aureus infection were five times more likely to die than control recipients who developed S. aureus infection. Investigators have suggested that a multiple-antigen vaccine would be more effective, but a lack of biomarkers defining human protective immunity keep these proposals in the logical, but strictly hypothetical arena.
1990 Thomas Jefferson Award from the University of Virginia Distinguished Alumni Award from the University of Minnesota Medical Alumni Association (2005) James D. Mills Award from the American College of Emergency Physicians (2008) Solomon A. Berson Award in Health Sciences from the New York University School of Medicine (2011).
== History == The StAR protein was first identified, characterized and named by Douglas Stocco at Texas Tech University Health Sciences Center in 1994. The role of this protein in lipoid CAH was confirmed the following year in collaboration with Walter Miller at the University of California, San Francisco. All of this work follows the initial observations of the appearance of this protein and its phosphorylated form coincident with factors that caused steroid production by Nanette Orme-Johnson while at Tufts University.
=== Primary classifications === Lacto-ovo vegetarianism (or ovo-lacto vegetarianism) includes animal products such as dairy, eggs, and honey. Lacto vegetarianism includes dairy and honey but not eggs. Ovo vegetarianism includes eggs and honey but not dairy. Veganism excludes all animal flesh and by-products, such as dairy, eggs, and honey, edible bird's nests and items refined or manufactured through any such product, such as animal-tested baking soda or white sugar refined with bone char. Within the "ovo-" groups, there are many who refuse to consume raw eggs (with balut being an extreme example); however, such distinction is typically not specifically addressed. Some vegetarians also avoid products that may use animal ingredients not included in their labels or which use animal products in their manufacturing. For example, sugars that are whitened with bone char, cheeses that use animal rennet (enzymes from animal stomach lining), gelatin (derived from the collagen inside animals' skin, bones, and connective tissues), some sugar cane (but not beet sugar), and beverages (such as apple juice and alcohol) clarified with gelatin or crushed shellfish and isinglass, while other vegetarians are unaware of, or do not mind, such ingredients. In the 21st century, 90% of rennet and chymosin used in cheesemaking are derived from industrial fermentation processes, which satisfy both kosher and halal requirements.
=== Nanotechnologies used in vitamin B12 supplementation === Conventional administration does not ensure specific distribution and controlled release of vitamin B12, for example to bone marrow and nerve cells. Nanocarrier strategies for improved vitamin B12 delivery remain embryonic as of 2021.
Sources: en.wikipedia.org
Willis, who predicted them using a dynamic homogenization method. Much of the recent interest in Willis couplings has been driven by their local form (the Milton–Briane–Willis equations). By extending Willis's homogenization method, Pernas-Salomón and Shmuel were the first to show that piezoelectric composites exhibit an effective coupling between linear momentum and the electric field, which they termed electro-momentum coupling. Electro-momentum coupling provides a mechanism for wave manipulation similar to Willis coupling, with the added benefit of electrical tunability.
Three structural isomers of L-tyrosine are known. In addition to the common amino acid L-tyrosine, which is the para isomer (para-tyr, p-tyr or 4-hydroxyphenylalanine), there are two additional regioisomers, namely meta-tyrosine (also known as 3-hydroxyphenylalanine, L-m-tyrosine, and m-tyr) and ortho-tyrosine (o-tyr or 2-hydroxyphenylalanine), that occur in nature. The m-tyr and o-tyr isomers, which are rare, arise through non-enzymatic free-radical hydroxylation of phenylalanine under conditions of oxidative stress. They are toxic to both animals and plants.
Fluid statics or hydrostatics is the branch of fluid mechanics that studies fluids at rest. It embraces the study of the conditions under which fluids are at rest in stable equilibrium; and is contrasted with fluid dynamics, the study of fluids in motion. Hydrostatics offers physical explanations for many phenomena of everyday life, such as why atmospheric pressure changes with altitude, why wood and oil float on water, and why the surface of water is always level whatever the shape of its container. Hydrostatics is fundamental to hydraulics, the engineering of equipment for storing, transporting and using fluids. It is also relevant to some aspects of geophysics and astrophysics (for example, in understanding plate tectonics and anomalies in the Earth's gravitational field), to meteorology, to medicine (in the context of blood pressure), and many other fields.
During the early phase of the investigation, much attention and media speculation fell on the anti-obesity supplement AOD-9604, which had appeared on consent forms and was acknowledged to have been administered in the program, including by Essendon captain Jobe Watson during a television interview. The legal status of AOD-9604 at the time of the program was uncertain: it was not explicitly listed as banned under Category S2 of the World Anti Doping Agency (WADA) code, but it had not been approved for human use by the Therapeutic Goods Administration and therefore could be considered as banned under the more general Category S0, which applied to any substances not approved for human use. The official position of WADA was that AOD-9604 had been considered a banned substance under Category S0 since 2011, and it clarified this publicly to ASADA on 22 April 2013. After considering its legal position, ASADA declared that it would not pursue any cases relating to AOD-9604 use before 22 April 2013, determining that it would be too difficult to achieve a guilty verdict for a supplement that had not yet explicitly been declared banned. Parallel to the AFL-ASADA investigation, Essendon commissioned former Telstra CEO Ziggy Switkowski to conduct a full independent review of governance and processes of the club. Switkowski's report, which was delivered on 6 May 2013, identified significant failings in governance which would later be repeated in ASADA's findings.
Sources: en.wikipedia.org
== Further reading == Harary, Isaac; Korey, Saul R.; Ochoa, Severo (August 1953). "Biosynthesis of dicarboxylic acids by carbon dioxide fixation. VII. Equilibrium of malic enzyme reaction". The Journal of Biological Chemistry. 203 (2): 595–604. doi:10.1016/S0021-9258(19)52329-8. PMID 13084629. Ochoa S, Mehler AH, Kornberg A (July 1948). "Biosynthesis of dicarboxylic acids by carbon dioxide fixation; isolation and properties of an enzyme from pigeon liver catalyzing the reversible oxidative decarboxylation of 1-malic acid". The Journal of Biological Chemistry. 174 (3): 979–1000. doi:10.1016/S0021-9258(18)57307-5. PMID 18871257. Rutter WJ, Lardy HA (August 1958). "Purification and properties of pigeon liver malic enzyme". The Journal of Biological Chemistry. 233 (2): 374–82. doi:10.1016/S0021-9258(18)64768-4. PMID 13563505. Stickland RG (December 1959). "Some properties of the malic enzyme of pigeon liver. 1. Conversion of malate into pyruvate". The Biochemical Journal. 73 (4): 646–54. doi:10.1042/bj0730646. PMC 1197115. PMID 13834656. Stickland RG (December 1959). "Some properties of the malic enzyme of pigeon liver. 2. Synthesis of malate from pyruvate". The Biochemical Journal. 73 (4): 654–9. doi:10.1042/bj0730654. PMC 1197116. PMID 13834657. Walker DA (February 1960). "Physiological studies on acid metabolism. 7. Malic enzyme from Kalanchoe crenata: effects of carbon dioxide concentration". The Biochemical Journal. 74 (2): 216–23. doi:10.1042/bj0740216. PMC 1204145. PMID 13842495.
== Protein A antibody binding == It has been shown via crystallographic refinement that the primary binding site for protein A is on the Fc region, between the CH2 and CH3 domains. In addition, protein A has been shown to bind human IgG molecules containing IgG F(ab')2 fragments from the human VH3 gene family. Protein A can bind with strong affinity to the Fc portion of immunoglobulin of certain species as shown in the below table.
== Research == A 2016 review found that reserpine reduced systolic blood pressure (SBP) by about 8 mmHg compared to placebo, and may be as effective at reducing SBP as other front-line hypertensive drugs, although more research is needed to determine a dose-specific safety profile.
=== Emulsion process === The concept of microemulsion is applied in this process. The transesterification involves sucrose and fatty acid methyl ester in a solvent, propylene glycol. A basic catalyst, such as anhydrous potassium carbonate, and soap, or a fatty acid salt, are added. The reaction is carried out at 130-135 °C. Propylene glycol is removed through distillation under vacuum at above 120 °C. The purified product is achieved by filtration. The yield of the reaction is 96%. 85% of sucrose esters is monosubstituted and 15% is disubstituted.
Though technically distinct from the alkanes, this class of hydrocarbons is referred to by some as the "cyclic alkanes." As their description implies, they contain one or more rings. Simple cycloalkanes have a prefix "cyclo-" to distinguish them from alkanes. Cycloalkanes are named as per their acyclic counterparts with respect to the number of carbon atoms in their backbones, e.g., cyclopentane (C5H10) is a cycloalkane with 5 carbon atoms just like pentane (C5H12), but they are joined up in a five-membered ring. In a similar manner, propane and cyclopropane, butane and cyclobutane, etc. Substituted cycloalkanes are named similarly to substituted alkanes – the cycloalkane ring is stated, and the substituents are according to their position on the ring, with the numbering decided by the Cahn–Ingold–Prelog priority rules.
Sources: en.wikipedia.org
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.
Typical endpoints include growth hormone pulse frequency and amplitude, together with insulin-like growth factor 1 concentration. Some protocols add body composition or metabolic markers. Interpretation depends on baseline hormonal status, which varies widely between individuals.
Most human data come from small, early-stage studies, and independent replication is limited. Short-term effects on growth hormone release are documented; longer-term outcomes are not well characterized. Open questions include changes in pituitary responsiveness after repeated exposure.
The mass difference from the linker is large enough for routine detection by mass spectrometry. The unconjugated form gives a single sharp signal at its expected weight. Material that has already reacted with albumin shows a much higher mass and a broadened chromatographic peak.